Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis
Yasutaka Kakinoki, Kazuki Yamada, Yoko Tanino, Keiko Suzuki, Takaya Ichikawa, Naoki Suzuki, Go Asari, Ai Nakamura, Shin Kukita, Akito Uehara, Seisuke Saito, Shohei Kuroda, Hidemitsu Sakagami, Yuuki Nagashima, Kae Takahashi, Satoshi Suzuki
doi: https://doi.org/10.1101/2021.10.10.21264589
Yasutaka Kakinoki
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Kazuki Yamada
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Yoko Tanino
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Keiko Suzuki
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Takaya Ichikawa
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Naoki Suzuki
2Asahikawa City Health Center, Asahikawa, Japan
Go Asari
2Asahikawa City Health Center, Asahikawa, Japan
Ai Nakamura
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Shin Kukita
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Akito Uehara
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Seisuke Saito
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Shohei Kuroda
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Hidemitsu Sakagami
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Yuuki Nagashima
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Kae Takahashi
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Satoshi Suzuki
1Division of Internal Medicine, Asahikawa City Hospital, Asahikawa, Japan
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted November 04, 2021.
Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis
Yasutaka Kakinoki, Kazuki Yamada, Yoko Tanino, Keiko Suzuki, Takaya Ichikawa, Naoki Suzuki, Go Asari, Ai Nakamura, Shin Kukita, Akito Uehara, Seisuke Saito, Shohei Kuroda, Hidemitsu Sakagami, Yuuki Nagashima, Kae Takahashi, Satoshi Suzuki
medRxiv 2021.10.10.21264589; doi: https://doi.org/10.1101/2021.10.10.21264589
Impact of Antibody Cocktail Therapy Combined with Casirivimab and Imdevimab on Clinical Outcome for Covid-19 patients in A Real-Life Setting: A Single Institute Analysis
Yasutaka Kakinoki, Kazuki Yamada, Yoko Tanino, Keiko Suzuki, Takaya Ichikawa, Naoki Suzuki, Go Asari, Ai Nakamura, Shin Kukita, Akito Uehara, Seisuke Saito, Shohei Kuroda, Hidemitsu Sakagami, Yuuki Nagashima, Kae Takahashi, Satoshi Suzuki
medRxiv 2021.10.10.21264589; doi: https://doi.org/10.1101/2021.10.10.21264589
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)